2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Micell Technologies: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease MiStent DES, Endeavor DES - Coronary Artery Disease | Phase 2 | Completed | Micell Technologies | 184 | 2011-02-01 | 2017-02-08 |
| First-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease MiStent SES - Coronary Artery Disease | Phase 2 | Completed | Micell Technologies | 30 | 2010-11-01 | 2016-12-19 |
Belgium (2) · New Zealand (2) · Australia (1) · France (1) · Netherlands (1) · Sweden (1) · United Kingdom (1)
William Wijns, MD (2) · John Ormiston, MD (1)